[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE18211T1 - Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen. - Google Patents

Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.

Info

Publication number
ATE18211T1
ATE18211T1 AT82306916T AT82306916T ATE18211T1 AT E18211 T1 ATE18211 T1 AT E18211T1 AT 82306916 T AT82306916 T AT 82306916T AT 82306916 T AT82306916 T AT 82306916T AT E18211 T1 ATE18211 T1 AT E18211T1
Authority
AT
Austria
Prior art keywords
group
carbon atoms
hydrogen atom
member selected
alkyl group
Prior art date
Application number
AT82306916T
Other languages
English (en)
Inventor
Masaaki Hamada
Kaoru Okamoto
Teikichi Kurosaki
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE18211T1 publication Critical patent/ATE18211T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT82306916T 1981-12-29 1982-12-23 Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen. ATE18211T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56211626A JPS58116466A (ja) 1981-12-29 1981-12-29 新規キノリル酢酸誘導体及び該化合物を含有する医薬組成物
EP82306916A EP0083222B1 (de) 1981-12-29 1982-12-23 Chinolinessigsäuren und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ATE18211T1 true ATE18211T1 (de) 1986-03-15

Family

ID=16608881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82306916T ATE18211T1 (de) 1981-12-29 1982-12-23 Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.

Country Status (10)

Country Link
US (1) US4555513A (de)
EP (1) EP0083222B1 (de)
JP (1) JPS58116466A (de)
KR (1) KR840002813A (de)
AT (1) ATE18211T1 (de)
AU (1) AU559732B2 (de)
CA (1) CA1192198A (de)
DE (1) DE3269533D1 (de)
DK (1) DK569082A (de)
ES (1) ES8406442A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0317061A (ja) * 1989-06-13 1991-01-25 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸酢酸誘導体
JP3209568B2 (ja) * 1991-04-16 2001-09-17 杏林製薬株式会社 新規環状アミノフェニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤
US5666014A (en) * 1994-07-20 1997-09-09 Mechanical Technology Inc. Velocity-controlled magnetic bearings
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
EP1807080A1 (de) * 2004-10-29 2007-07-18 AstraZeneca AB Verwendung von ungesättigten chinolin- oder naphthalin-derivaten als medikamente

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2042352A1 (fr) * 1969-04-21 1971-02-12 Ciba Geigy Ag Acides alpha-(1,2,3,4-tetrahydro-6-quinolyl)-carboxyliques et leurs derives
CH567477A5 (de) * 1972-03-10 1975-10-15 Ciba Geigy Ag
FR2278338A1 (fr) * 1974-07-15 1976-02-13 Bouchara Emile Derives de la dihydro-1-2 trimethyl-2-2-4 quinoleine et application comme medicaments
CH628892A5 (it) * 1977-06-22 1982-03-31 Simes Procedimento per la preparazione di acidi chinolinici ad attivita antiinfiammatoria.
JPS54128584A (en) * 1978-03-28 1979-10-05 Teijin Ltd Novel 3,4-dihydrocarbostyril derivative

Also Published As

Publication number Publication date
AU9181382A (en) 1983-07-07
CA1192198A (en) 1985-08-20
EP0083222A1 (de) 1983-07-06
AU559732B2 (en) 1987-03-19
DK569082A (da) 1983-06-30
DE3269533D1 (en) 1986-04-03
US4555513A (en) 1985-11-26
ES518613A0 (es) 1984-08-01
JPH037670B2 (de) 1991-02-04
JPS58116466A (ja) 1983-07-11
EP0083222B1 (de) 1986-02-26
KR840002813A (ko) 1984-07-21
ES8406442A1 (es) 1984-08-01

Similar Documents

Publication Publication Date Title
IL73893A (en) 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE10199003I2 (de)
ES8306141A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo
GR3005315T3 (de)
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ES8306142A1 (es) "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas".
ES8801230A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
ES8507090A1 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
ES8504738A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES479820A1 (es) Procedimiento para la preparacion de isoquinoleinas.
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
DE69103630D1 (de) Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
ES435361A1 (es) Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos.
ES479440A1 (es) Un procedimiento para preparar compuestos con propiedades broncodilatadoras.
ES2007784A6 (es) Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea>
ES8103047A1 (es) Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios
ES8106714A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos
ES8304532A1 (es) "procedimiento de preparacion de derivados de etanolamina".
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media
HU9702541D0 (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties